Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 5-(2-formyl-3-methoxyphenoxy)pentanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

77858-24-3

Post Buying Request

77858-24-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77858-24-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 77858-24-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,8,5 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 77858-24:
(7*7)+(6*7)+(5*8)+(4*5)+(3*8)+(2*2)+(1*4)=183
183 % 10 = 3
So 77858-24-3 is a valid CAS Registry Number.

77858-24-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 5-(2-formyl-3-methoxyphenoxy)pentanoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77858-24-3 SDS

77858-24-3Relevant academic research and scientific papers

Pharmaceutical ethers

-

, (2008/06/13)

This invention is directed to novel ether compounds of formula (I) STR1 which are of value in medicine in the palliation of haemoglobinopathies, in particular sickle-cell anaemia, and also in the palliation of pulmonary dysfunction, protection from the effects of hypoxia and the radio-sensitization of tumors. The invention is also directed to methods for the preparation of the ether compounds, to pharmaceutical formulations containing them, the preparation of such formulations and the use of the compounds in human medicine. Also provided by the invention are intermediates of value in the preparation of the ether compounds, by the methods described, and the preparation of the intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 77858-24-3